Press Releases
Please view the latest press from Enzo Biochem, Inc.
| Date | Details |
| Tuesday July 20, 2021 | ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR RAPID EXTRACTION METHOD ON PROPRIETARY TEST SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2 |
| Tuesday June 15, 2021 | Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel |
| Wednesday June 09, 2021 | Enzo Biochem Reports Third Quarter Fiscal 2021 Results |
| Tuesday June 01, 2021 | Enzo Biochem to Report Third Quarter 2021 Financial Results on Wednesday, June 9 |
| Wednesday April 21, 2021 | Enzo’s Universal AMPICOLLECT™ Used on GENFLEX® Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization |
| Wednesday March 17, 2021 | ENZO BIOCHEM TO PRESENT AT THE KEYBANC CAPITAL MARKETS' LIFE SCIENCES & MEDTECH INVESTOR FORUM |
| Monday March 15, 2021 | Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates |
| Thursday March 04, 2021 | Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference |
| Tuesday March 02, 2021 | Enzo Announces its GENFLEX™ Molecular Test Detects Current COVID-19 Variants |
| Monday March 01, 2021 | Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15 |
| Wednesday February 03, 2021 | Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin |
| Wednesday January 20, 2021 | ENZO BIOCHEM’S BOARD OF DIRECTORS FORMS NEW CORPORATE DEVELOPMENT AND PLANNING & SUCCESSION COMMITTEES |
| Tuesday January 05, 2021 | ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT |
| Monday January 04, 2021 | ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR TESTING POOLED SAMPLES ON THREE PLATFORMS INCLUDING COMPANY’S GENFLEX™ PROPRIETARY SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2 |